The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Gracie

Forum Topics Started

Viewing 6 topics - 1 through 6 (of 6 total)

- TOPIC
- Help, fast growing tumors, which B Raf?
  Started by: Gracie General Melanoma Community
- 3
- 18
- TracyLee
  
  13 years, 6 months ago
- Help, fast growing tumors, which B Raf?
  Started by: Gracie General Melanoma Community
- 0
- 0
- Gracie
  
  13 years, 6 months ago
- Please help – IL2 after Ipi?
  Started by: Gracie General Melanoma Community
- 6
- 22
- debbieVA
  
  13 years, 8 months ago
- Please help – IL2 after Ipi?
  Started by: Gracie General Melanoma Community
- 2
- 6
- jim Breitfeller
  
  13 years, 8 months ago
- Stage IV treatment options?
  Started by: Gracie General Melanoma Community
- 3
- 6
- King
  
  13 years, 8 months ago
- Does the Ipi cause a “welt-like” rash?
  Started by: Gracie General Melanoma Community
- 5
- 10
- JenC
  
  14 years, 4 months ago

Viewing 6 topics - 1 through 6 (of 6 total)

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.